SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
04-May-20 8:55 PM View: | McDonnell Peter J Director | Allergan Plc (AGN) | 01-May-22 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (13%) 7.34K to 6.35K | |
11-May-20 9:48 PM View: | Bailey A Robert D EVP Chief Legal Off & Corp Sec | Allergan Plc (AGN) | 08-May-20 | Disposition | 34,429 | -- | -- | (100%) 34.43K to 0 | |
11-May-20 9:34 PM View: | Coughlin Christopher J Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 16,532 | -- | -- | (28%) 59.15K to 42.62K | |
11-May-20 9:54 PM View: | Bodine Chris W Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 18,615 | -- | -- | (100%) 18.61K to 0 | |
11-May-20 9:39 PM View: | Meury William EVP & Chief Commercial Officer | Allergan Plc (AGN) | 08-May-20 | Disposition | 32,635 | -- | -- | (100%) 32.63K to 0 | |
11-May-20 9:41 PM View: | Nicholson C. David EVP Chief R&D Officer | Allergan Plc (AGN) | 08-May-20 | Disposition | 35,200 | -- | -- | (100%) 35.2K to 0 | |
11-May-20 9:58 PM View: | Hugin Robert J Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 4,294 | -- | -- | (100%) 4.29K to 0 | |
11-May-20 9:37 PM View: | McDonnell Peter J Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 6,352 | -- | -- | (100%) 6.35K to 0 | |
11-May-20 9:50 PM View: | Darecca James SVP Chief Accounting Officer | Allergan Plc (AGN) | 08-May-20 | Disposition | 9,835 | -- | -- | (100%) 9.84K to 0 | |
11-May-20 9:36 PM View: | Saunders Brent L Chairman, President and CEO Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 229,189 | -- | -- | (100%) 229.19K to 0 | |
11-May-20 9:46 PM View: | Freyman Thomas C Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 2,983 | -- | -- | (100%) 2.98K to 0 | |
12-May-20 6:17 AM View: | Basgoz Nesli Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 6,889 | -- | -- | (100%) 6.89K to 0 | |
11-May-20 9:41 PM View: | Greenberg Michael Eldon Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 1,693 | -- | -- | (100%) 1.69K to 0 | |
11-May-20 9:44 PM View: | Walsh Matthew M EVP, Chief Financial Officer | Allergan Plc (AGN) | 08-May-20 | Disposition | 39,657 | -- | -- | (100%) 39.66K to 0 | |
11-May-20 9:34 PM View: | Coughlin Christopher J Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 10,009 | -- | -- | (14%) 69.16K to 59.15K | |
12-May-20 6:09 AM View: | Boccuzi Joseph H Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 3,605 | -- | -- | (100%) 3.6K to 0 | |
11-May-20 9:44 PM View: | Davidson Carol Anthony Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 2,105 | -- | -- | (100%) 2.1K to 0 | |
11-May-20 9:48 PM View: | Brown Adriane M Director | Allergan Plc (AGN) | 08-May-20 | Disposition | 2,916 | -- | -- | (100%) 2.92K to 0 | |
11-May-20 9:42 PM View: | Swanton Wayne R EVP, Global Operations | Allergan Plc (AGN) | 08-May-20 | Disposition | 20,965 | -- | -- | (100%) 20.96K to 0 | |
04-May-20 9:02 PM View: | Basgoz Nesli Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (13%) 7.88K to 6.89K | |
04-May-20 8:59 PM View: | Brown Adriane M Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (25%) 3.91K to 2.92K | |
04-May-20 8:58 PM View: | Freyman Thomas C Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 2,064 | $189.74 | $391,623.00 | (41%) 5.05K to 2.98K | |
04-May-20 8:59 PM View: | Greenberg Michael Eldon Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (37%) 2.68K to 1.69K | |
04-May-20 9:00 PM View: | Davidson Carol Anthony Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (32%) 3.1K to 2.1K | |
04-May-20 9:00 PM View: | Coughlin Christopher J Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (4%) 27.54K to 26.55K | |
04-May-20 8:57 PM View: | Boccuzi Joseph H Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (22%) 4.6K to 3.6K | |
04-May-20 8:56 PM View: | Bodine Chris W Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 991 | $189.74 | $188,032.00 | (5%) 19.61K to 18.61K | |
04-May-20 8:55 PM View: | Hugin Robert J Director | Allergan Plc (AGN) | 01-May-20 | Payment of Exercise | 2,064 | $189.74 | $391,623.00 | (32%) 6.36K to 4.29K | |
04-May-20 9:02 PM View: | Basgoz Nesli Director | Allergan Plc (AGN) | 13-Apr-20 | Gift | 280 | -- | -- | (3%) 8.16K to 7.88K | |
07-Apr-20 6:28 PM View: | Bailey A Robert D EVP Chief Legal Off & Corp Sec | Allergan Plc (AGN) | 03-Apr-20 | Payment of Exercise | 581 | $175.71 | $102,088.00 | (2%) 35.01K to 34.43K | |
07-Apr-20 6:29 PM View: | Meury William EVP & Chief Commercial Officer | Allergan Plc (AGN) | 03-Apr-20 | Payment of Exercise | 855 | $175.71 | $150,232.00 | (3%) 33.49K to 32.63K | |
10-Mar-20 2:10 PM View: | Darecca James SVP Chief Accounting Officer | Allergan Plc (AGN) | 06-Mar-20 | Payment of Exercise | 718 | $191.95 | $137,820.00 | (7%) 10.55K to 9.83K | |
10-Mar-20 2:12 PM View: | Swanton Wayne R EVP, Global Operations | Allergan Plc (AGN) | 06-Mar-20 | Payment of Exercise | 199 | $191.95 | $38,198.10 | (< 1%) 21.16K to 20.96K | |
04-Mar-20 2:22 PM View: | Darecca James SVP Chief Accounting Officer | Allergan Plc (AGN) | 02-Mar-20 | Grant | 3,611 | $193.84 | $699,956.00 | 52% 6.94K to 10.55K | |
04-Mar-20 2:16 PM View: | Saunders Brent L Chairman, President and CEO Director | Allergan Plc (AGN) | 02-Mar-20 | Grant | 68,613 | $193.84 | $13,299,900.00 | 43% 160.58K to 229.19K | |
04-Mar-20 2:17 PM View: | Walsh Matthew M EVP, Chief Financial Officer | Allergan Plc (AGN) | 02-Mar-20 | Grant | 15,476 | $193.84 | $2,999,870.00 | 64% 24.18K to 39.66K | |
04-Mar-20 2:23 PM View: | Swanton Wayne R EVP, Global Operations | Allergan Plc (AGN) | 02-Mar-20 | Grant | 8,770 | $193.84 | $1,699,980.00 | 71% 12.39K to 21.16K | |
04-Mar-20 2:24 PM View: | Nicholson C. David EVP Chief R&D Officer | Allergan Plc (AGN) | 02-Mar-20 | Grant | 21,667 | $193.84 | $4,199,930.00 | 151% 14.3K to 35.97K | |
04-Mar-20 2:17 PM View: | Bailey A Robert D EVP Chief Legal Off & Corp Sec | Allergan Plc (AGN) | 02-Mar-20 | Grant | 14,444 | $193.84 | $2,799,820.00 | 70% 20.56K to 35.01K | |
04-Mar-20 2:21 PM View: | Meury William EVP & Chief Commercial Officer | Allergan Plc (AGN) | 02-Mar-20 | Grant | 21,667 | $193.84 | $4,199,930.00 | 183% 11.82K to 33.49K | |
07-Apr-20 6:30 PM View: | Nicholson C. David EVP Chief R&D Officer | Allergan Plc (AGN) | 02-Mar-20 | Grant | 21,667 | $193.84 | $4,199,930.00 | 151% 14.3K to 35.97K | |
02-Jan-20 5:51 PM View: | Bailey A Robert D EVP Chief Legal Off & Corp Sec | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 1,313 | $191.17 | $251,006.00 | (6%) 21.88K to 20.56K | |
02-Jan-20 5:52 PM View: | Darecca James SVP Chief Accounting Officer | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 92 | $191.17 | $17,587.60 | (1%) 7.03K to 6.94K | |
02-Jan-20 5:53 PM View: | Meury William EVP & Chief Commercial Officer | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 1,504 | $191.17 | $287,520.00 | (11%) 13.33K to 11.82K | |
02-Jan-20 5:55 PM View: | Nicholson C. David EVP Chief R&D Officer | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 1,031 | $191.17 | $197,096.00 | (7%) 15.34K to 14.3K | |
02-Jan-20 5:57 PM View: | Swanton Wayne R EVP, Global Operations | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 146 | $191.17 | $27,910.80 | (1%) 12.54K to 12.39K | |
02-Jan-20 5:49 PM View: | Saunders Brent L Chairman, President and CEO Director | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 7,333 | $191.17 | $1,401,850.00 | (4%) 167.91K to 160.58K | |
16-Dec-19 2:01 PM View: | Swanton Wayne R EVP, Global Operations | Allergan Plc (AGN) | 12-Dec-19 | Payment of Exercise | 488 | $188.27 | $91,875.80 | (4%) 13.03K to 12.54K | |
09-Dec-19 4:23 PM View: | Basgoz Nesli Director | Allergan Plc (AGN) | 06-Dec-19 | Gift | 47 | -- | -- | (< 1%) 8.21K to 8.16K | |
13-Feb-20 10:00 PM View: | Coughlin Christopher J Director | Allergan Plc (AGN) | 18-Jun-19 | Gift | 9,538 | -- | -- | (26%) 37.08K to 27.54K |